Second Resection and New Methods of Tumor Visualization in Bladder Cancer
Yunus Erol Bozkurt (Author), Turgay Turan (Author)
Release Date: 2024-05-28
The chapter delves into the necessity and outcomes of secondary resection following transurethral resection of bladder tumor (TURBT). Furthermore, the chapter highlights the importance of timing between primary and secondary resections and explores various factors affecting the accuracy and success of TURBT operation.Transitioning to innovative tumor visualization methods, the chapter introduces Photodynamic Diagnosis (PDD), Narrow [...]
Media Type
PDF
Buy from
Price may vary by retailers
Work Type | Book Chapter |
---|---|
Published in | Current Management of Non-Muscle Invasive Bladder Cancer |
First Page | 89 |
Last Page | 95 |
DOI | https://doi.org/10.69860/nobel.9786053359197.7 |
ISBN | 978-605-335-919-7 (PDF) |
Language | ENG |
Page Count | 7 |
Copyright Holder | Nobel Tıp Kitabevleri |
License | https://nobelpub.com/publish-with-us/copyright-and-licensing |
Yunus Erol Bozkurt (Author)
MD, Manisa Merkez Efendi State Hospital
https://orcid.org/0000-0002-9894-9489
3Born in 1988 in Malatya, I completed my medical education at Ege University Faculty of Medicine from 2006 to 2012. Subsequently, I pursued specialization in urology at the Department of Urology, Manisa Celal Bayar University Faculty of Medicine, spanning from 2013 to 2020. Since 2020, I have served as a urology specialist at Manisa Merkez Efendi State Hospital. With expertise in andrology and functional urology, I have authored articles in these fields.
Turgay Turan (Author)
Izmir Democracy University
https://orcid.org/0000-0002-4951-6396
3Born in 1978 in Tokat, I completed my medical education at 19 Mayıs University Faculty of Medicine from 1997 to 2003. Following this, I pursued my specialization in urology at Health Sciences University, Umraniye Training and Research Hospital, Department of Urology from 2006 to 2011. In 2019, I earned the title of Associate Professor in the field of Urology. Since 2022, I have been serving as a Urology Specialist at the Department of Urology, Faculty of Medicine, Izmir Democracy University. I have expertise in Urooncology and Endourology and have authored several articles in these fields. Throughout my career, I have been dedicated to advancing medical knowledge and improving patient care, while also teaching and mentoring medical students and residents. I am proficient in advanced surgical techniques and clinical research, and I am committed to providing specialized urological care to patients."
1. EAU Guidelines. Edn. presented at the EAU Annual Congress Milan 2023. ISBN 978-94-92671-19-6.
2. Eroglu A, Ekin RG, Koc G, Divrik RT. The prognostic value of routine second transurethral resection in patients with newly diagnosed stage pT1 non-muscle-invasive bladder cancer: results from randomized 10-year extension trial. Int J Clin Oncol. 2020 Apr;25(4):698-704.
3. Palou J, Pisano F, Sylvester R, Joniau S, Serretta V, Larré S, et al. Recurrence, progression, and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought. World J Urol. 2018 Oct;36(10):1621-1627.
4. Kamiya N, Suzuki H, Suyama T, Kobayashi M, Fukasawa S, Sekita N et al. Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study. Int J Clin Oncol. 2017 Apr;22(2):353-358.
5. Ferro M, Vartolomei MD, Cantiello F, Lucarelli G, Di Stasi SM, Hurle R, et al. High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study. Urol Int. 2018;101(1):7-15.
6. Baltacı S, Bozlu M, Yıldırım A, Gökçe Mİ, Tinay İ, Aslan G, Can C, et al. Significance of the interval between first and second transurethral resection on recurrence and progression rates in patients with high-risk non-muscle-invasive bladder cancer treated with maintenance intravesical Bacillus Calmette-Guérin. BJU Int. 2015 Nov;116(5):721-6..
7. Gallioli A, Diana P, Fontana M, Territo A, Rodriguez-Faba Ó, Gaya JM, et al. En Bloc Versus Conventional Transurethral Resection of Bladder Tumors: A Single-center Prospective Randomized Noninferiority Trial. Eur Urol Oncol. 2022 Aug;5(4):440-448.
8. D’Andrea D, Soria F, Hurle R, Enikeev D, Kotov S, Régnier S, et al; eBLOC Study Team. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. 2023 Oct;6(5):508-515.
9. Zhou W, Wang W, Wu W, Yan T, Du G, Liu H. Can a second resection be avoided after initial thulium laser endoscopic en bloc resection for non-muscle invasive bladder cancer? A retrospective single-center study of 251 patients. BMC Urol. 2020 Mar 18;20(1):30.
10. Yanagisawa T, Sato S, Hayashida Y, Okada Y, Iwatani K, Matsukawa A, et al. Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer? BJU Int. 2023 Feb;131(2):190-197.
11. Inoue K. 5-Aminolevulinic acid-mediated photodynamic therapy for bladder cancer. Int J Urol. 2017 Feb;24(2):97-101.
12. Chen C, Huang H, Zhao Y, Liu H, Luo Y, Sylvester RJ, Li JP et la. Diagnostic accuracy of photodynamic diagnosis with 5-aminolevulinic acid, hexaminolevulinate and narrow band imaging for non-muscle invasive bladder cancer. J Cancer. 2020 Jan 1;11(5):1082-1093.
13. Bochenek K, Aebisher D, Międzybrodzka A, Cieślar G, Kawczyk-Krupka A. Methods for bladder cancer diagnosis - The role of autofluorescence and photodynamic diagnosis. Photodiagnosis Photodyn Ther. 2019 Sep;27:141-148.
14. Fukuhara H, Yamamoto S, Lai HW, Karashima T, Kurabayashi A, Furihata M et al. Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (2nd report): Reduced bladder recurrence after PDD-TURBT. Photodiagnosis Photodyn Ther. 2022 Jun;38:102757.
15. Drejer D, Moltke AL, Nielsen AM, Lam GW, Jensen JB. DaBlaCa-11: Photodynamic Diagnosis in Flexible Cystoscopy-A Randomized Study with Focus on Recurrence. Urology. 2020 Mar;137:91-96.
16. Naselli A, Puppo P. Narrow band imaging and bladder cancer: when and how. Urologia. 2015 Oct;82 Suppl 2:S5-8.
17. Gravestock P, Coulthard N, Veeratterapillay R, Heer R. Response to Re: Systematic review and meta-analysis of narrow band imaging for non-muscle-invasive bladder cancer. Int J Urol. 2022 Apr;29(4):366-367.
18. Tschirdewahn S, Harke NN, Hirner L, Stagge E, Hadaschik B, Eisenhardt A. Narrow-band imaging assisted cystoscopy in the follow-up of patients with transitional cell carcinoma of the bladder: a randomized study in comparison with white light cystoscopy. World J Urol. 2020 Jun;38(6):1509-1515.
19. Trelles Guzmán CR, Linares Espinós E, Ríos González E, Alonso Dorrego JM, Aguilera Bazán A, Jiménez Romero ME, et al. Randomized clinical trial on the use of IMAGE1 S LIGHT (SPIES) vs. white light in the prevention of recurrence during transurethral resection of bladder tumors: Analysis after 12-month follow-up. Actas Urol Esp (Engl Ed). 2023 Dec 28:S2173-5786(23)00141-5. English, Spanish.
20. Jeffrey M. Howard, Solomon L. Woldu, Siamak Daneshmand, Yair Lotan Enhanced. Endoscopy with IMAGE1 S CHROMA improves detection of nonmuscle invasive bladder cancer during transurethral resection. Journal of Endourology 2021 35:5, 647-651
21. Boschi, F., & Malatesta, M. (2023). Nanoparticle-based techniques for bladder cancer imaging: A Review. Int J Mol Sci., 24(4), 3812.
onix_3.0::thoth | Thoth ONIX 3.0 |
---|---|
onix_3.0::project_muse | Project MUSE ONIX 3.0 |
onix_3.0::oapen | OAPEN ONIX 3.0 |
onix_3.0::jstor | JSTOR ONIX 3.0 |
onix_3.0::google_books | Google Books ONIX 3.0 |
onix_3.0::overdrive | OverDrive ONIX 3.0 |
onix_2.1::ebsco_host | EBSCO Host ONIX 2.1 |
csv::thoth | Thoth CSV |
json::thoth | Thoth JSON |
kbart::oclc | OCLC KBART |
bibtex::thoth | Thoth BibTeX |
doideposit::crossref | CrossRef DOI deposit |
onix_2.1::proquest_ebrary | ProQuest Ebrary ONIX 2.1 |
marc21record::thoth | Thoth MARC 21 Record |
marc21markup::thoth | Thoth MARC 21 Markup |
marc21xml::thoth | Thoth MARC 21 XML |